BlackRock »

Aim Immunotech shares owned by BlackRock

Quarter-by-quarter ownership of Aim Immunotech (AIM) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Aim Immunotech

Tip: Access up to 7 years of quarterly data

All positions including Aim Immunotech held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aim Immunotech by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $189k 698k 0.27

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Aim Immunotech

Armistice Capital
Vanguard Group
BlackRock
BlackRock
Geode Capital Management
Citadel Advisors
Renaissance Technologies
State Street Corporation
Verition Fund Management
Two Sigma Securities
Virtu Financial
Bridgeway Capital Management
Morgan Stanley
Northern Trust
SeaCrest Wealth Management

View all funds holding Aim Immunotech